Eine vollständige Bewerbung in einer Minute
Maßgeschneiderter Lebenslauf und Anschreiben – versandbereit.
METHODIQ, a brand of ODDITY, is seeking a Senior Analyst/Manager to lead new product development for telemedicine categories and to guide strategy from ideation through launch. You will work closely with leadership to define roadmaps, prioritize initiatives, and drive execution across multiple workstreams.
You will manage a high-velocity team, collaborate with data science, technology product, and marketing, and build relationships with key suppliers and contract organizations to ensure
We are seeking a highly qualified entrepreneurial Senior Analysts & Managers to join the team on the ground floor as we scale METHODIQ to new product launches & new telemedicine categories. In this role, you will work closely with our leadership team to bring METHODIQ categories vision to life—to define and set strategy, plan, prioritize, build, and execute. You will work dynamically from ideation through launch, working cross-functionally across multiple workstreams to deliver on the brand’s strategic objectives.
What you will do:
Who you are:
Base Salary Range:
Exact responsibilities & job title subject to professional work experience. While the published salary range is a good faith reflection of the targeted salary level for the position, Oddity reserves the right to pay outside of the published salary range of $85K-115K.
About ODDITY:
ODDITY is a consumer-tech company which builds and scales digital-first brands to disrupt offline dominated categories. In less than a decade years since launch, we have built three of the fastest-growing online beauty brands in the US—IL MAKIAGE, SpoiledChild, and METHODIQ. Our first two brands have grown to unprecedented scale online, reaching over $800 million in revenue and 60 million users. ODDITY New Ventures built and launched our third brand METHODIQ in early 2025 – a consumer telehealth platform with a revolutionary dermatology product suite enhanced by proprietary formulations, patented biotechnology, computer vision, and unprecedented product personalization.